Epithalon + Thymosin Alpha-1
Epithalon + Thymosin Alpha-1 is the most evidence-backed longevity peptide combination, drawn directly from the Russian longitudinal research programme conducted at the St. Petersburg Gerontology Institute. Epithalon targets cellular ageing via telomerase activation and pineal regulation, while Thymosin Alpha-1 restores the age-related immune decline caused by thymic involution. Together they address two of the most critical drivers of biological ageing: telomere erosion and immune senescence.
Stack Components
This blend combines 2 research peptides with complementary mechanisms designed to produce synergistic outcomes.
Synergy Rationale
Ageing is characterised by two converging immune-cellular failures: telomeres shorten with each cell division, progressively impairing cellular function and ultimately driving senescence; simultaneously, the thymus involutes (shrinks), producing fewer functional T-cells and degrading the adaptive immune response. This combination directly targets both.
Epithalon activates telomerase to arrest and partially reverse telomere shortening — protecting immune cells themselves from the senescence that would impair their function. Thymosin Alpha-1 then enhances the function of the T-cells that Epithalon helps preserve, creating a compounding effect on immune competence.
The 25-year Russian longitudinal studies used exactly this combination (biannual thymalin + epithalamin courses) and observed a 2-fold reduction in mortality, markedly reduced cancer incidence, and preserved cognitive function in treated elderly cohorts — providing a unique human dataset for any peptide combination in longevity research.
Combined Mechanism of Action
Epithalon activates telomerase (hTERT) in human somatic cells, enabling telomere extension. It also stimulates the pineal gland's melatonin output — melatonin being a potent antioxidant and circadian synchroniser whose decline is strongly correlated with accelerated ageing.
Thymosin Alpha-1 activates toll-like receptors on dendritic cells, enhances Th1 cytokine production, promotes T-cell maturation in the thymus, and reduces immunosuppressive Treg activity. This multi-pronged immune restoration is the mechanism behind its clinical approval for viral hepatitis and cancer immunotherapy support.
Together: Epithalon provides the cellular longevity substrate (intact, functioning cells with preserved telomeres), while Thymosin Alpha-1 ensures those cells are immunologically competent — addressing both the hardware (cellular integrity) and the software (immune function) of biological longevity.
Research Evidence
This is the most human-data-supported peptide combination in longevity research. The Khavinson/Anisimov longitudinal studies are unique in providing decade-scale follow-up data on a peptide intervention in human subjects.
25-Year Follow-Up: Peptide Bioregulation Reduces Mortality in the Elderly
266 elderly patients receiving biannual courses of thymalin + epithalamin showed 2-fold lower mortality, reduced cardiovascular and oncological incidence, and preserved neuropsychological status versus matched controls over 12 years of active treatment.
Thymosin Alpha-1 in Combination Immunotherapy Shows Additive Survival Benefits
Meta-analysis of cancer trials with Tα1 adjunct therapy showed consistent survival benefit versus standard care alone across multiple tumour types, consistent with Tα1's immune surveillance restoration mechanism.
Component Dosing Protocol
The traditional Russian protocol runs Epithalon as a 10-day course at 5–10mg/day. Thymosin Alpha-1 is administered twice weekly for 6 weeks flanking the Epithalon course. Some practitioners run Tα1 monthly at maintenance (1.6mg weekly) year-round with the Epithalon course twice yearly as a "reset".
Safety Considerations
Reported Side Effects
- Injection site redness (both)
- Mild flu-like symptoms (Tα1 first injection)
- Vivid dreams (Epithalon — pineal modulation)
- Transient fatigue
Contraindications
- Active autoimmune disease (Tα1 immune stimulation risk)
- Active malignancy (Epithalon telomerase concern)
- Post-transplant immunosuppression
- Pregnancy
Frequently Asked Questions
Is this the same protocol used in the Russian longevity studies?
The Russian studies used thymalin (a natural thymic extract) and epithalamin (a natural pineal extract) rather than the purified synthetic forms used today. Epithalon (synthetic) is the active tetrapeptide of epithalamin; Thymosin Alpha-1 (synthetic) overlaps with but is not identical to the thymalin extract. The synthetic forms are considered more precise and reproducible.
How often should this protocol be repeated?
The Russian longitudinal data used biannual (twice yearly) courses — typically spring and autumn. Some anti-aging practitioners use Thymosin Alpha-1 monthly at maintenance dosing (weekly 1.6mg injections) with the Epithalon course reserved for twice-yearly intensive use. Annual or biannual use is the minimum frequency supported by the published outcomes data.
What biomarkers should I track on this longevity stack?
Useful monitoring includes: telomere length testing (baseline + annual, though expensive), immune function panels (T-cell subsets, NK cell activity), circulating MOTS-c and Humanin levels if available, IGF-1 (Epithalon raises GH/IGF-1 through pineal effects), melatonin circadian rhythm, and standard metabolic/inflammatory markers (hsCRP, IL-6). Annual comprehensive blood work is the minimum practical monitoring approach.
Can this stack be used by younger adults (under 40)?
The Russian research was conducted primarily in elderly populations where telomere erosion and immune senescence are established. In younger adults (under 40), where telomeres are generally intact and thymic function is less impaired, the risk-benefit calculus is different. Thymosin Alpha-1 is generally considered safe at any age for immune support. Epithalon is more commonly reserved for middle age and beyond, though some younger researchers use it in shorter courses.
Does this stack affect sleep?
Yes — both compounds influence sleep quality. Epithalon stimulates pineal melatonin production, which directly improves circadian rhythm and sleep depth. Vivid dreams during Epithalon courses are commonly reported. Thymosin Alpha-1 does not directly affect sleep but its immune-modulating effects may reduce systemic inflammation that impairs sleep quality. The stack is often deliberately timed in the evening for this reason.
Key Research References
- Khavinson VKh et al. (2009). Peptide regulation of aging: 35-year research experience. Bull Exp Biol Med.
- Goldstein AL et al. (2009). History and overview of Thymosin Alpha-1. Ann NY Acad Sci.
Explore more peptide combination stacks
Browse All Blends →